From the Podium to Your Practice: Dr. Jonathan Silverberg Reviews New Data Showing That Upadacitinib Beat Dupilumab Across All Ranked Secondary End Points in Head-to-head AD Trial
https://vimeo.com/958694329?share=copy Jonathan Silverberg, MD, PhD, MPH, Director of Clinical Research at The George Washington University School of Medicine and Health Sciences in Washington, DC, breaks down the new data from LEVEL-UP, a head-to-head study evaluating upadacitinib (Rinvoq, AbbVie) vs. dupilumab (Dupixent, Sanofi & Regeneron) for the treatment of adolescents and adults with moderate to severe atopic dermatitis who […]